Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depigmented polymerized Dermatophagoides pteronyssinus extract for mild allergic asthma in children
2006-000571-15Phase 2Active
- Sponsor
- LETI Pharma
- Start
- May 2007
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of depigmented polymerized Dermatophagoides pteronyssinus allergen extract in asthma and house dust mite allergy (2 arms), sponsored by LETI Pharma. Primary endpoint: Clinical efficacy. Started May 2007; status: active.
02
Drugs
depigmented polymerized Dermatophagoides pteronyssinus allergen extract
03
Conditions
asthmahouse dust mite allergy
Beyond the preview
Go deeper on 2006-000571-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000571-15.